1. |
Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 50 cancers in 1990 [J]. Int J Cancer, 1993; 83(1)∶18.
|
2. |
American Joint Committee on Cancer. AJCC Cancer Staging [M]. 5th ed. New York, NY: Springer, 2002∶131-138.
|
3. |
楊秉輝. 第四屆全國肝癌學術會議概況及關于肝癌診斷標準及分期問題討論 [J]. 中華普通外科雜志,2000; 15(4)∶238.
|
4. |
Frilling A, Malago M, Broelsch CE. Current status of liver transplantation for treatment of hepatocellular carcinoma [J]. Dig Dis, 2001; 19(4)∶333.
|
5. |
文天夫. 原發性肝癌的預后. 見: 嚴律南主編. 肝臟外科 [M]. 北京: 人民衛生出版社,2002∶479~509.
|
6. |
王槐志,董家鴻,王曙光,等. 肝移植治療原發性肝癌 [J]. 實用臨床醫藥雜志,2003; 7(1)∶27.
|
7. |
Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma [J]. Hepatology,2002; 35(5)∶1164.
|
8. |
嚴律南,李波,盧實春,等. 原位肝移植術中體外靜脈轉流時機的改進 [J]. 外科理論與實踐,2002; 7(2)∶1220.
|
9. |
嚴律南. 肝硬變門脈高壓癥的肝臟移植經驗 [J]. 中國普外基礎與臨床雜志,2001; 8(4)∶263.
|